Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Customized class switch of immunoglobulin genes in lymphoma and hybridoma by CRISPR/CAS9 technology

Customized class switch of immunoglobulin genes in lymphoma and hybridoma by CRISPR/CAS9 technology

US Patent 11530253 · Granted Dec 20, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

High throughput genome-wide translocation sequencing2019
Complex of a protein comprising zinc oxide-binding peptides and zinc oxide nanop2017
Anaplastic lymphoma kinase (ALK) as oncoantigen for lymphoma vaccination2017
High throughput genome-wide translocation sequencing2016
Anaplastic lymphoma kinase (ALK) as oncoantigen for lymphoma vaccination2015